Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Tài liệu Báo cáo khoa học: Solution NMR structure of an immunodominant epitope of myelin basic
Nội dung xem thử
Mô tả chi tiết
Solution NMR structure of an immunodominant epitope
of myelin basic protein
Conformational dependence on environment of an intrinsically
unstructured protein
Christophe Fare` s1,*, David S. Libich1 and George Harauz1
1 Department of Molecular and Cellular Biology, and Biophysics Interdepartmental Group, University of Guelph, Canada
Multiple sclerosis is characterized by chronic inflammation of the myelin in the central nervous system (CNS),
and major variants of the illness are considered to be
primarily autoimmune in nature [1]. The 18.5 kDa
isoform of myelin basic protein (MBP) is one of the
most abundant proteins in CNS myelin; MBP maintains
the compaction of the sheath by anchoring the cytoplasmic faces of the oligodendrocyte membranes [2], and is a
candidate antigen for T cells and autoantibodies in
multiple sclerosis [3]. The three-dimensional structure of
MBP has not yet been elucidated to high resolution
[4,5]. We recently used site-directed spin-labeling
Keywords
correlation spectroscopy; multiple sclerosis;
myelin basic protein; immunodominant
epitope; solution NMR
Correspondence
G. Harauz, Department of Molecular and
Cellular Biology, and Biophysics
Interdepartmental Group, University of
Guelph, 50 Stone Road East, Guelph,
Ontario, Canada, N1G 2W1
Fax: +1 519 837 2075
Tel: +1 519 824 4120, ext. 52535
E-mail: [email protected]
*Present address
Max-Planck-Institut fu¨r Biophysikalische
Chemie, NMR-Based Structural Biology,
Go¨ttingen, Germany.
Christophe Fare` s and David S. Libich contributed equally to this work.
(Received 19 October 2005, revised
1 December 2005, accepted 7 December
2005)
doi:10.1111/j.1742-4658.2005.05093.x
Using solution NMR spectroscopy, three-dimensional structures have been
obtained for an 18-residue synthetic polypeptide fragment of 18.5 kDa
myelin basic protein (MBP, human residues Q81–T98) under three conditions emulating the protein’s natural environment in the myelin membrane
to varying degrees: (a) an aqueous solution (100 mm KCl pH 6.5), (b) a
mixture of trifluoroethanol (TFE-d2) and water (30 : 70% v ⁄ v), and (c) a
dispersion of 100 mm dodecylphosphocholine (DPC-d38, 1 : 100 protein ⁄ lipid molar ratio) micelles. This polypeptide sequence is highly conserved in MBP from mammals, amphibians, and birds, and comprises a
major immunodominant epitope (human residues N83–T92) in the autoimmune disease multiple sclerosis. In the polypeptide fragment, this epitope
forms a stable, amphipathic, a helix under organic and membrane-mimetic
conditions, but has only a partially helical conformation in aqueous solution. These results are consistent with recent molecular dynamics simulations that showed this segment to have a propensity to form a transient
a helix in aqueous solution, and with electron paramagnetic resonance
(EPR) experiments that suggested a a-helical structure when bound to a
membrane [I. R. Bates, J. B. Feix, J. M. Boggs & G. Harauz (2004) J Biol
Chem, 279, 5757–5764]. The high sensitivity of the epitope structure to its
environment is characteristic of intrinsically unstructured proteins, like
MBP, and reflects its association with diverse ligands such as lipids and
other proteins.
Abbreviations
CNS, central nervous system; CSI, chemical shift index; DIPSI, decoupling in the presence of scalar interactions; DPC-d38, perdeuterated
dodecylphosphatidylcholine; DSA, doxylstearic acid; EPR, electron paramagnetic resonance; Fmoc, 9-fluorenylmethoxycarbonyl; gpMBP,
guinea pig myelin basic protein; hMBP, human myelin basic protein; MAP, mitogen-activated protein; MBP, myelin basic protein; MHC,
major histocompatibility complex; rmMBP, recombinant murine; RMSD, root mean squared deviation; SDSL, site-directed spin-labeling; SH3,
Src homology domain 3; TFE-d2, deuterated 2,2,2-trifluoroethanol (CF3-CD2-OH); TSP, 3-(trimethylsilyl)-propionic acid.
FEBS Journal 273 (2006) 601–614 ª 2006 The Authors Journal compilation ª 2006 FEBS 601